VERSANT VENTURE CAPITAL VI, L.P.

PrivateCIK: 1687880
Location

SAN FRANCISCO, CA

VERSANT VENTURE CAPITAL VI, L.P. sold 22.7% of their position (224.97K shares) of LENZ THERAPEUTICS, INC. on the open market

Open‑market sale worth $10.35M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 6 sales
IssuerLENZ THERAPEUTICS, INC.CIK 1815776
10% Owner
Since Jun 2021
-224.97K
Net shares
Net seller
$10.35M
Total sold
6
Open market trades
0B · 6S
6
Total transactions
224.97K disposed
Non-Derivative Transactions6

Common Stock

Direct
S · Sale

Shares

49.70K

Price / share

$45.35

Trade value

$2.25M

% of position

4.2%
9/30/2025
1.18M1.13M

Common Stock

Indirect
S · Sale

Shares

34.41K

Price / share

$45.35

Trade value

$1.56M

% of position

4.0%
9/30/2025
856.16K821.75K

Common Stock

Direct
S · Sale

Shares

83.07K

Price / share

$46.41

Trade value

$3.85M

% of position

7.3%
9/30/2025
1.13M1.05M

Common Stock

Indirect
S · Sale

Shares

57.50K

Price / share

$46.41

Trade value

$2.67M

% of position

7.0%
9/30/2025
821.75K764.25K

Common Stock

Direct
S · Sale

Shares

177.00

Price / share

$47.01

Trade value

$8.32K

% of position

0.0%
9/30/2025
1.05M1.05M

Common Stock

Indirect
S · Sale

Shares

123.00

Price / share

$47.01

Trade value

$5.78K

% of position

0.0%
9/30/2025
764.25K764.13K
Total

Net shares

224.97K

Net value

-$10.35M

Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1

Common Stock

Indirect
Shares owned842.16K
Total
842.16K indirect842.16K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
VERSANT VENTURE CAPITAL VI, L.P. — Insider Transaction (Form 4) Filed Oct 2, 2025 | Finecho